SMTL ID : 6knr.2 (1 other biounit)

Crystal structure of Estrogen-related receptor gamma ligand-binding domain with DN200699

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x DL9: (E)-4-(1-(4-(1-cyclopropylpiperidin-4-yl)phenyl)-5-hydroxy-2-phenylpent-1-en-1-yl)phenol(Non-covalent)

DL9.1: 24 residues within 4Å: Chain A: L.50, L.53, C.54, L.56, A.57, D.58, E.60, L.61, W.90, M.91, L.94, I.95, V.98, R.101, Y.111, L.127, L.130, N.131, I.134, A.216, H.219, F.220, I.223, F.235 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:L.53, A:L.56, A:A.57, A:A.57, A:W.90, A:W.90, A:L.94, A:L.94, A:V.98, A:Y.111, A:F.220, A:I.223, A:F.235 Hydrogen bonds: A:E.60, A:R.101, A:Y.111 Water bridges: A:V.98 Salt bridges: A:D.58 pi-Stacking: A:F.220 pi-Cation interactions: A:F.235

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kim, J. et al., An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer. Eur.J.Med.Chem. (2020)

Release Date

2020-08-12

Peptides

Estrogen-related receptor gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Estrogen-related receptor gamma

Related Entries With Identical Sequence